Neurology News

Chronic inflammation appeared linked to neurodegenerative brain changes that affect cognitive ability differences in later life, according to study results published in Neurology.

Antithrombotic use after a transient focal neurological episode, as well as motor forms of these episodes, increased risk for lobar intracerebral hemorrhage, according to results of a systematic review and meta-analysis.

A machine learning model that uses the most basic raw data may help physicians identify patients who need referrals to social workers and predict their risk for hospitalization.

Compared with cancer survivors, stroke survivors were less likely to quit smoking, with nearly 40% continuing to smoke after the stroke, suggested new data.

Ketamine improved neurocognitive outcomes at 24 hours among patients with depression and suicidal ideation, according to study results published in Journal of Clinical Psychiatry.

In a company release, Accuray Inc. announced its CyberKnife radiotherapy platform, which delivers stereotactic radiosurgery to treat lesions in the brain, was supported by more than 2 decades of globally driven clinical data.

Brigham and Women’s Hospital will soon commence a clinical trial to test the first nasally administered treatment intended to arrest the progression of Alzheimer’s disease, according to a press release.

A smartphone application may help clinicians detect concussion biomarkers, according to study results published in Life.

The FDA has granted approval to Insightec for Exablate Neuro, a new device for treating patients with advanced Parkinson's disease who suffer from mobility, rigidity or dyskinesia symptoms, according to a press release.

Researchers reported common causes of death and end-of-life care experiences among patients with intracranial high-grade gliomas in a retrospective observational study published in Neurology.